Vifor Boosts US Nephrology Prospects With Janssen Pact
Vifor: Selling Invokana In DKD Could Aid Veltassa’s US sales
Vifor has boosted its US nephrology prospects with a pact with Janssen to jointly market Invokana in diabetic kidney disease.
Vifor has boosted its US nephrology prospects with a pact with Janssen to jointly market Invokana in diabetic kidney disease.